Amniotics AB (publ) 66J.F Stock
Amniotics AB (publ) Price Chart
Amniotics AB (publ) 66J.F Financial and Trading Overview
| Amniotics AB (publ) stock price | 0.0002 EUR |
| Previous Close | 0.007 EUR |
| Open | 0.007 EUR |
| Bid | 0.0044 EUR x N/A |
| Ask | 0.0094 EUR x N/A |
| Day's Range | 0.007 - 0.007 EUR |
| 52 Week Range | 0.0002 - 0.58 EUR |
| Volume | 384K EUR |
| Avg. Volume | 7.69K EUR |
| Market Cap | 902.94K EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
66J.F Valuation Measures
| Enterprise Value | 820.99K EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Amniotics AB (publ) Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -98.055% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.58 EUR |
| 52 Week Low | 0.0002 EUR |
| 50-Day Moving Average | 0.006148 EUR |
| 200-Day Moving Average | 0.13 EUR |
66J.F Share Statistics
| Avg. Volume (3 month) | 7.69K EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 117.28M |
| Float | 105.56M |
| Short Ratio | N/A |
| % Held by Insiders | 9.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -55.17% |
| Return on Equity (ttm) | -200.48% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.936 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Amniotics AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | ScheelevAegen 2 |
| ZIP | 22381 |
| Phone | 46 0 72 32 78 520 |
| Website | https://www.amniotics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 14 |
Amniotics AB (publ) develops stem cell-based therapeutics to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; CutiStem for the treatment of dermatological indications; and AMNI-NK003. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.
Q&A For Amniotics AB (publ) Stock
What is a current 66J.F stock price?
Amniotics AB (publ) 66J.F stock price today per share is 0.0002 EUR.
How to purchase Amniotics AB (publ) stock?
You can buy 66J.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Amniotics AB (publ)?
The stock symbol or ticker of Amniotics AB (publ) is 66J.F.
Which industry does the Amniotics AB (publ) company belong to?
The Amniotics AB (publ) industry is Biotechnology.
How many shares does Amniotics AB (publ) have in circulation?
The max supply of Amniotics AB (publ) shares is 4.63B.
What is Amniotics AB (publ) Price to Earnings Ratio (PE Ratio)?
Amniotics AB (publ) PE Ratio is now.
What was Amniotics AB (publ) earnings per share over the trailing 12 months (TTM)?
Amniotics AB (publ) EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Amniotics AB (publ) company belong to?
The Amniotics AB (publ) sector is Healthcare.